Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Environ Int. 2023 Oct;180:108197. doi: 10.1016/j.envint.2023.108197. Epub 2023 Sep 14.
Per- and polyfluoroalkyl substances (PFAS) are environmentally persistent organic pollutants detectable in the serum of most U.S. adults. We previously reported a positive association between serum perfluorooctanoate (PFOA) concentrations and risk of renal cell carcinoma (RCC) within the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, comprising predominantly White individuals enrolled in 1993-2001. To extend our investigations to a larger and more racially and ethnically diverse population, we conducted a nested case-control study of serum PFAS concentrations and RCC within the Multiethnic Cohort Study. We measured pre-diagnostic serum concentrations of nine PFAS among 428 RCC cases and 428 individually matched controls. We estimated odds ratios (ORs) and 95 % confidence intervals (CIs) for risk of RCC in relation to each PFAS using conditional logistic regression, adjusting for RCC risk factors and other PFAS. PFOA was not associated with RCC risk overall [doubling in serum concentration, OR = 0.89 (95 %CI = 0.67, 1.18)]. However, we observed suggestive positive associations among White participants [2.12 (0.87, 5.18)] and among participants who had blood drawn before 2002 [1.49 (0.77, 2.87)]. Furthermore, higher perfluorononanoate (PFNA) concentration was associated with increased risk of RCC overall [fourth vs. first quartile, OR = 1.84 (0.97, 3.50), P = 0.04; OR = 1.29 (0.97, 1.71)], with the strongest association observed among African American participants [OR = 3.69 (1.33, 10.25)], followed by Native Hawaiian [2.24 (0.70, 7.19)] and White [1.98 (0.92, 4.25)] participants. Most other PFAS were not associated with RCC. While PFOA was not associated with RCC risk overall in this racially and ethnically diverse population, the positive associations observed among White participants and those with sera collected before 2002 are consistent with previous PLCO findings. Our study also provided new evidence of a positive association between PFNA and RCC risk that was strongest in African American participants. These findings highlight the need for additional epidemiologic research investigating PFAS exposures and RCC in large racially and ethnically diverse populations.
全氟和多氟烷基物质(PFAS)是在大多数美国成年人的血清中可检测到的环境持久性有机污染物。我们之前报告了血清中全氟辛酸(PFOA)浓度与前列腺癌、肺癌、结直肠癌和卵巢癌(PLCO)筛查试验中肾细胞癌(RCC)风险之间的正相关关系,该试验主要由 1993 年至 2001 年期间招募的白种人组成。为了将我们的研究扩展到更大的、种族和民族更加多样化的人群中,我们在多民族队列研究中进行了一项关于血清 PFAS 浓度与 RCC 的巢式病例对照研究。我们测量了 428 例 RCC 病例和 428 例个体匹配对照者的预诊断血清中 9 种 PFAS 的浓度。我们使用条件逻辑回归,在调整了 RCC 风险因素和其他 PFAS 后,估计了每种 PFAS 与 RCC 风险之间的比值比(OR)和 95%置信区间(CI)。总体而言,PFOA 与 RCC 风险无关[血清浓度翻倍,OR=0.89(95%CI=0.67,1.18)]。然而,我们在白种人参与者中观察到了提示性的阳性关联[2.12(0.87,5.18)],以及在 2002 年之前采血的参与者中观察到了阳性关联[1.49(0.77,2.87)]。此外,全氟壬酸(PFNA)浓度较高与 RCC 风险总体增加相关[第四四分位与第一四分位相比,OR=1.84(0.97,3.50),P=0.04;OR=1.29(0.97,1.71)],在非裔美国参与者中观察到最强的关联[OR=3.69(1.33,10.25)],其次是夏威夷原住民[2.24(0.70,7.19)]和白种人[1.98(0.92,4.25)]。大多数其他 PFAS 与 RCC 无关。虽然在这个种族和民族多样化的人群中,PFOA 与 RCC 风险总体上没有关联,但在白种人和 2002 年前采血的参与者中观察到的阳性关联与之前的 PLCO 研究结果一致。我们的研究还提供了新的证据,表明 PFNA 与 RCC 风险之间存在正相关,在非裔美国参与者中这种关联最强。这些发现强调了在大型种族和民族多样化人群中进行更多流行病学研究以调查 PFAS 暴露与 RCC 之间关系的必要性。